Advance Search | Bentham Science

Challenges and Opportunities for Cancer Vaccines in the Current NSCLC Clinical Scenario

Journal: Current Topics in Medicinal Chemistry
Volume: 13 Issue: 20 Year: 2013 Page: 2551-2561
Author(s): Pedro C. Rodriguez,Belinda Sanchez

Selumetinib in Advanced Non Small Cell Lung Cancer (NSCLC) Harbouring KRAS Mutation: Endless Clinical Challenge to KRAS-mutant NSCLC.

Journal: Reviews on Recent Clinical Trials
Volume: 8 Issue: 2 Year: 2013 Page: 93-100
Author(s): Paolo Maione,Assunta Sgambato,Antonio Rossi,Paola Claudia Sacco,Maria Anna Bareschino,Clorinda Schettino,Francesca Casaluce,Fortunato Ciardiello,Cesare Gridelli

New Molecular Targets in the Treatment of NSCLC

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5333-5343
Author(s): Clorinda Schettino, Maria Anna Bareschino, Paola Claudia Sacco, Paolo Maione, Antonio Rossi, Francesca Casaluce, Assunta Sgambato, Cesare Gridelli

Molecular Mechanisms and Modulation of Key Pathways Underlying the Synergistic Interaction of Sorafenib with Erlotinib in Non-Small-Cell-Lung Cancer (NSCLC) Cells

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 927-939
Author(s): E. Giovannetti,M. Labots,H. Dekker,E. Galvani,J.S.W. Lind,R. Sciarrillo,R. Honeywell,E.F. Smit,H.M. Verheul,G.J. Peters

Integrated Therapeutic Approaches in the Treatment of Locally Advanced Non-small Cell Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 6 Year: 2013 Page: 844-851
Author(s): Massimo Di Maio,Raffaele Costanzo,Pasqualina Giordano,Maria Carmela Piccirillo,Claudia Sandomenico,Agnese Montanino,Guido Carillio,Paolo Muto,David R. Jones,Gennaro Daniele,Francesco Perrone,Gaetano Rocco,Alessandro Morabito

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 818-832
Author(s): Elena Galvani,Roberta Alfieri,Elisa Giovannetti,Andrea Cavazzoni,Silvia La Monica,Maricla Galetti,Claudia Fumarola,Mara Bonelli,Marco Mor,Marcello Tiseo,Godefridus J. Peters,Pier Giorgio Petronini,Andrea Ardizzoni

Tumor Markers in Patients with Benign and Malignant Pulmonary Diseases; Competitive Evaluation of ProGRP, NSE and Cyfra 21-1

Journal: Recent Patents on Biomarkers
Volume: 3 Issue: 2 Year: 2013 Page: 145-152
Author(s): Bijan B. Dilmaghani-Marand, Gerhard M. Oremek

The PARAMOUNT Trial: A Phase III Randomized Study of Maintenance Pemetrexed Versus Placebo Immediately Following Induction First-line Treatment with Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 8 Issue: 1 Year: 2013 Page: 23-28
Author(s): Cesare Gridelli,Paolo Maione,Antonio Rossi

Metabolite Characterization of Anti-cancer Agent Gefitinib in Human Hepatocytes

Journal: Drug Metabolism Letters
Volume: 7 Issue: 2 Year: 2013 Page: 126-136
Author(s): Prashant Surve,Selvan Ravindran,Arghya Acharjee,Himanshu Rastogi,Sudipta Basu,Pradnya Honrao

Targeting Neuronal Nicotinic Receptors in Cancer: New Ligands and Potential Side-Effects

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 8 Issue: 1 Year: 2013 Page: 38-52
Author(s): Paola Ambrosi,Andrea Becchetti

Search

Find Journals, Volumes, Issues, Articles, Ebooks and Chapters

Search Result "NSCLC"